Patents Assigned to ORAMED LTD.
  • Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
    Publication number: 20240358647
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Application
    Filed: December 22, 2023
    Publication date: October 31, 2024
    Applicant: Oramed Ltd.
    Inventors: Avraham HERSHKO, Miriam KIDRON
  • Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
    Publication number: 20240181018
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of norialcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Application
    Filed: December 21, 2023
    Publication date: June 6, 2024
    Applicant: ORAMED LTD.
    Inventors: Miriam KIDRON, Ehud ARBIT
  • METHODS AND COMPOSITIONS FOR TREATING DIABETES
    Publication number: 20230210956
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: June 29, 2022
    Publication date: July 6, 2023
    Applicant: ORAMED LTD.
    Inventor: MIRIAM KIDRON
  • Methods and compositions for oral administration of proteins
    Patent number: 11660327
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: May 30, 2023
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Methods and compositions for treating diabetes
    Patent number: 11395848
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: July 26, 2022
    Assignee: ORAMED LTD.
    Inventor: Miriam Kidron
  • Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
    Publication number: 20220000986
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Application
    Filed: March 19, 2021
    Publication date: January 6, 2022
    Applicant: ORAMED LTD.
    Inventors: Miriam KIDRON, Ehud ARBIT
  • Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
    Publication number: 20210369626
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Application
    Filed: February 1, 2021
    Publication date: December 2, 2021
    Applicant: Oramed Ltd.
    Inventors: Avraham HERSHKO, Miriam KIDRON
  • Methods and Compositions for Oral Administration of Proteins
    Publication number: 20210113663
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 22, 2021
    Applicant: Oramed Ltd.
    Inventor: Miriam KIDRON
  • Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
    Patent number: 10967051
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: April 6, 2021
    Assignee: Oramed Ltd.
    Inventors: Miriam Kidron, Ehud Arbit
  • Methods and Compositions for Treating Diabetes
    Publication number: 20210077588
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: March 23, 2020
    Publication date: March 18, 2021
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
    Patent number: 10933022
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: March 2, 2021
    Assignee: Oramed Ltd.
    Inventors: Avraham Hershko, Miriam Kidron
  • Methods and compositions for oral administration of proteins
    Patent number: 10881714
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: January 5, 2021
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Methods and Compositions for Treating Diabetes
    Publication number: 20190374615
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: August 27, 2019
    Publication date: December 12, 2019
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
    Publication number: 20190321303
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Application
    Filed: May 9, 2019
    Publication date: October 24, 2019
    Applicant: Oramed Ltd.
    Inventors: Avraham Hershko, Miriam Kidron
  • Methods and Compositions for Rectal Administration of Exenatide
    Publication number: 20190314275
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Application
    Filed: June 10, 2019
    Publication date: October 17, 2019
    Applicant: Oramed Ltd.
    Inventor: Miriam Kidron
  • Methods and compositions for treating diabetes
    Patent number: 10398762
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analog.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: September 3, 2019
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Methods and compositions for oral administration of exenatide
    Patent number: 10350162
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: July 16, 2019
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
    Publication number: 20190209655
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Application
    Filed: November 19, 2018
    Publication date: July 11, 2019
    Applicant: ORAMED LTD.
    Inventors: Miriam Kidron, Ehud Arbit
  • Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
    Patent number: 10342764
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: July 9, 2019
    Assignee: Oramed Ltd.
    Inventors: Avraham Hershko, Miriam Kidron
  • Methods and Compositions for Oral Administration of Proteins
    Publication number: 20180369339
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Application
    Filed: July 27, 2018
    Publication date: December 27, 2018
    Applicant: Oramed Ltd.
    Inventor: Miriam Kidron